Armata Pharmaceuticals (ARMP) Current Deferred Revenue (2013 - 2018)
Armata Pharmaceuticals (ARMP) reported Current Deferred Revenue of $335000.0 for Q4 2018, up 1575.0% sequentially from $20000.0 in Q3 2017.
Armata Pharmaceuticals (ARMP) Current Deferred Revenue (2013 - 2018) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 6 years of Current Deferred Revenue data on file, last reported at $335000.0 in Q4 2018.
- For the quarter ending Q4 2018, Current Deferred Revenue changed N/A year-over-year to $335000.0; the trailing twelve-month figure through Dec 2018 stood at $335000.0 (changed N/A YoY), and the FY2018 full-year result was $335000.0, changed N/A from the prior year.
- Current Deferred Revenue improved to $335000.0 in Q4 2018, from $20000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $350000.0 in Q2 2015 to a low of $18000.0 in Q3 2016.
- A 5-year average of $177666.7 and a median of $142000.0 in 2015 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue plunged 92.71% in 2016 and soared 34.88% in 2017, its largest moves.
- Tracing ARMP's Current Deferred Revenue over 5 years: stood at $244000.0 in 2014, then rose by 0.41% to $245000.0 in 2015, then plunged by 92.65% to $18000.0 in 2016, then climbed by 11.11% to $20000.0 in 2017, then soared by 1575.0% to $335000.0 in 2018.
- Business Quant data shows ARMP's Current Deferred Revenue at $335000.0 in Q4 2018, $20000.0 in Q3 2017, and $58000.0 in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 335,000.00 |
| Sep 30, 2017 | 20,000.00 |
| Jun 30, 2017 | 58,000.00 |
| Mar 31, 2017 | 86,000.00 |
| Sep 30, 2016 | 18,000.00 |
| Jun 30, 2016 | 43,000.00 |
| Mar 31, 2016 | 142,000.00 |
| Dec 31, 2015 | 245,000.00 |
| Sep 30, 2015 | 247,000.00 |
| Jun 30, 2015 | 350,000.00 |
| Mar 31, 2015 | 142,000.00 |
| Dec 31, 2014 | 244,000.00 |
| Sep 30, 2014 | 246,000.00 |
| Jun 30, 2014 | 349,000.00 |
| Mar 31, 2014 | 140,000.00 |
| Dec 31, 2013 | 244,000.00 |